25 articles for thisTarget
              
              The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Synthesis and biological evaluation of a unique heparin mimetic hexasaccharide for structure-activity relationship studies.

Momenta Pharmaceuticals
 
Improved total synthesis and biological evaluation of potent apratoxin S4 based anticancer agents with differential stability and further enhanced activity.

University of Florida
 
Bioassay-guided isolation of proanthocyanidins with antiangiogenic activities.

University of Salerno
 
A focused sulfated glycoconjugate Ugi library for probing heparan sulfate-binding angiogenic growth factors.

The University of Queensland
 
Synthesis and biological evaluation of polysulfated oligosaccharide glycosides as inhibitors of angiogenesis and tumor growth.

Progen Pharmaceuticals
 
Recent progress in the development of hypoxia-inducible factor 2α (HIF-2α) modulators: Inhibitors, agonists, and degraders (2009-2024).

Hubei Polytechnic University
 
Discovery of a Dual Tubulin and Neuropilin-1 (NRP1) Inhibitor with Potent In Vivo Anti-Tumor Activity via Pharmacophore-based Docking Screening, Structure Optimization, and Biological Evaluation.

China Pharmaceutical University
 
Dimer Peptide Ligands of Vascular Endothelial Growth Factor: Optimizing Linker Length for High Affinity and Antiangiogenic Activity.

University Paris Cite
 
Synthesis, biological activity, and preliminary pharmacokinetic evaluation of analogues of a phosphosulfomannan angiogenesis inhibitor (PI-88).

Progen Industries
 
1,4-DIHETEROCYCLIC SUBSTITUTED AROMATIC RING OR AROMATIC HETEROCYCLIC COMPOUND AND USE THEREOF

Bebetter Med
 
PYRIDINO-OR PYRIMIDO-CYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF

Genfleet Therapeutics (Shanghai)
 
HSD17B13 INHIBITORS AND/OR DEGRADERS

Pfizer
 
AMPK activators

Kallyope
 
Cyanopyrrolidine derivatives as inhibitors for DUBs

Mission Therapeutics
 
Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors

Boehringer Ingelheim International
 
Pyrrolidine derivatives and their use as complement pathway modulators

Novartis
 
Quaternized amines as sodium channel blockers

Purdue Pharma
 
Design, synthesis and SAR study of hydroxychalcone inhibitors of human ß-secretase (BACE1).

Shanghai Institute of Material Medica, Chinese Academy of Sciences
 
Pyrrolo[3,2-c]pyridine tropomyosin-related kinase inhibitors

Pfizer
 
Flap modulators

Janssen Pharmaceutica
 
1′-substituted pyrimidine N-nucleoside analogs for antiviral treatment

Gilead Sciences
 
MAPK/ERK kinase inhibitors

Takeda Pharmaceutical